- Home
- INFU vs SEER Comparison
INFU vs SEER Comparison
Compare INFU & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INFU
- SEER
- Stock Information
- Founded
- INFU 2005
- SEER 2017
- Country
- INFU United States
- SEER United States
- Employees
- INFU N/A
- SEER 134
- Industry
- INFU Medical/Dental Instruments
- SEER Medicinal Chemicals and Botanical Products
- Sector
- INFU Health Care
- SEER Health Care
- Exchange
- INFU Nasdaq
- SEER Nasdaq
- Market Cap
- INFU 104.4M
- SEER 121.8M
- IPO Year
- INFU N/A
- SEER 2020
- Fundamental
- Price
- INFU $5.39
- SEER $1.84
- Analyst Decision
- INFU
- SEER Hold
- Analyst Count
- INFU 0
- SEER 1
- Target Price
- INFU N/A
- SEER $3.00
- AVG Volume (30 Days)
- INFU 123.2K
- SEER 174.6K
- Earning Date
- INFU 05-08-2025
- SEER 05-13-2025
- Dividend Yield
- INFU N/A
- SEER N/A
- EPS Growth
- INFU 3654.89
- SEER N/A
- EPS
- INFU 0.15
- SEER N/A
- Revenue
- INFU $137,582,000.00
- SEER $14,170,000.00
- Revenue This Year
- INFU $10.91
- SEER $23.54
- Revenue Next Year
- INFU $8.18
- SEER $42.98
- P/E Ratio
- INFU $36.63
- SEER N/A
- Revenue Growth
- INFU 7.98
- SEER N/A
- 52 Week Low
- INFU $4.61
- SEER $1.56
- 52 Week High
- INFU $9.97
- SEER $2.63
- Technical
- Relative Strength Index (RSI)
- INFU 57.20
- SEER 41.77
- Support Level
- INFU $4.67
- SEER $1.88
- Resistance Level
- INFU $5.61
- SEER $1.97
- Average True Range (ATR)
- INFU 0.22
- SEER 0.10
- MACD
- INFU 0.11
- SEER -0.02
- Stochastic Oscillator
- INFU 76.84
- SEER 0.00
About INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.